PRIVIA HEALTH GROUP INC (PRVA) Fundamental Analysis & Valuation

NASDAQ:PRVA • US74276R1023

Current stock price

24.02 USD
+0.52 (+2.21%)
At close:
24.0345 USD
+0.01 (+0.06%)
After Hours:

This PRVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. PRVA Profitability Analysis

1.1 Basic Checks

  • PRVA had positive earnings in the past year.
  • PRVA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
  • In the past 5 years PRVA always reported a positive cash flow from operatings.
PRVA Yearly Net Income VS EBIT VS OCF VS FCFPRVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • PRVA has a Return On Assets (1.67%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 3.11%, PRVA is in line with its industry, outperforming 58.00% of the companies in the same industry.
  • With a Return On Invested Capital value of 2.75%, PRVA perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for PRVA is significantly below the industry average of 8.51%.
  • The 3 year average ROIC (2.17%) for PRVA is below the current ROIC(2.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.67%
ROE 3.11%
ROIC 2.75%
ROA(3y)1.75%
ROA(5y)-4.65%
ROE(3y)3.16%
ROE(5y)-7.26%
ROIC(3y)2.17%
ROIC(5y)N/A
PRVA Yearly ROA, ROE, ROICPRVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • With a Profit Margin value of 1.08%, PRVA perfoms like the industry average, outperforming 57.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of PRVA has declined.
  • PRVA has a Operating Margin of 1.61%. This is comparable to the rest of the industry: PRVA outperforms 45.00% of its industry peers.
  • In the last couple of years the Operating Margin of PRVA has declined.
  • PRVA has a worse Gross Margin (9.87%) than 74.00% of its industry peers.
  • PRVA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.61%
PM (TTM) 1.08%
GM 9.87%
OM growth 3YN/A
OM growth 5Y-12.3%
PM growth 3YN/A
PM growth 5Y-22.33%
GM growth 3Y-0.24%
GM growth 5Y-0.49%
PRVA Yearly Profit, Operating, Gross MarginsPRVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PRVA Health Analysis

2.1 Basic Checks

  • PRVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, PRVA has more shares outstanding
  • PRVA has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRVA Yearly Shares OutstandingPRVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
PRVA Yearly Total Debt VS Total AssetsPRVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 4.64 indicates that PRVA is not in any danger for bankruptcy at the moment.
  • PRVA has a better Altman-Z score (4.64) than 82.00% of its industry peers.
  • PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.64
ROIC/WACC0.31
WACC8.9%
PRVA Yearly LT Debt VS Equity VS FCFPRVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.60 indicates that PRVA should not have too much problems paying its short term obligations.
  • PRVA's Current ratio of 1.60 is fine compared to the rest of the industry. PRVA outperforms 64.00% of its industry peers.
  • A Quick Ratio of 1.60 indicates that PRVA should not have too much problems paying its short term obligations.
  • PRVA has a better Quick ratio (1.60) than 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
PRVA Yearly Current Assets VS Current LiabilitesPRVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PRVA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.55% over the past year.
  • PRVA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
  • Looking at the last year, PRVA shows a very strong growth in Revenue. The Revenue has grown by 22.26%.
  • The Revenue has been growing by 21.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)54.55%
EPS 3Y9.35%
EPS 5Y-9.93%
EPS Q2Q%133.33%
Revenue 1Y (TTM)22.26%
Revenue growth 3Y16.09%
Revenue growth 5Y21.04%
Sales Q2Q%-31.71%

3.2 Future

  • PRVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.08% yearly.
  • The Revenue is expected to grow by 10.44% on average over the next years. This is quite good.
EPS Next Y109.45%
EPS Next 2Y64.03%
EPS Next 3Y57.08%
EPS Next 5YN/A
Revenue Next Year17.3%
Revenue Next 2Y13.96%
Revenue Next 3Y11.91%
Revenue Next 5Y10.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. PRVA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 141.29 indicates a quite expensive valuation of PRVA.
  • Compared to the rest of the industry, the Price/Earnings ratio of PRVA is on the same level as its industry peers.
  • PRVA is valuated expensively when we compare the Price/Earnings ratio to 27.89, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 67.46, the valuation of PRVA can be described as expensive.
  • PRVA's Price/Forward Earnings ratio is in line with the industry average.
  • PRVA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 38.50.
Industry RankSector Rank
PE 141.29
Fwd PE 67.46
PRVA Price Earnings VS Forward Price EarningsPRVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

  • PRVA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PRVA is more expensive than 62.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PRVA is valued a bit cheaper than the industry average as 64.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.47
EV/EBITDA 57.49
PRVA Per share dataPRVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PRVA's earnings are expected to grow with 57.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.29
PEG (5Y)N/A
EPS Next 2Y64.03%
EPS Next 3Y57.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PRVA Dividend Analysis

5.1 Amount

  • PRVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRVA Fundamentals: All Metrics, Ratios and Statistics

PRIVIA HEALTH GROUP INC

NASDAQ:PRVA (4/17/2026, 8:00:00 PM)

After market: 24.0345 +0.01 (+0.06%)

24.02

+0.52 (+2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners99.13%
Inst Owner Change0.08%
Ins Owners1.81%
Ins Owner Change5.08%
Market Cap3.02B
Revenue(TTM)2.12B
Net Income(TTM)22.92M
Analysts84.29
Price Target33.06 (37.64%)
Short Float %2.11%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)43.55%
Min EPS beat(2)-8.97%
Max EPS beat(2)96.08%
EPS beat(4)1
Avg EPS beat(4)-2.92%
Min EPS beat(4)-60.96%
Max EPS beat(4)96.08%
EPS beat(8)1
Avg EPS beat(8)-23.29%
EPS beat(12)3
Avg EPS beat(12)-1.19%
EPS beat(16)6
Avg EPS beat(16)61.33%
Revenue beat(2)1
Avg Revenue beat(2)5.86%
Min Revenue beat(2)-6.18%
Max Revenue beat(2)17.91%
Revenue beat(4)3
Avg Revenue beat(4)4.55%
Min Revenue beat(4)-6.18%
Max Revenue beat(4)17.91%
Revenue beat(8)7
Avg Revenue beat(8)4.33%
Revenue beat(12)10
Avg Revenue beat(12)3.07%
Revenue beat(16)10
Avg Revenue beat(16)-7.25%
PT rev (1m)2.82%
PT rev (3m)2.73%
EPS NQ rev (1m)-3.01%
EPS NQ rev (3m)10.44%
EPS NY rev (1m)1.65%
EPS NY rev (3m)11.12%
Revenue NQ rev (1m)3.08%
Revenue NQ rev (3m)-1.43%
Revenue NY rev (1m)3.08%
Revenue NY rev (3m)-36.11%
Valuation
Industry RankSector Rank
PE 141.29
Fwd PE 67.46
P/S 1.42
P/FCF 18.47
P/OCF 18.47
P/B 4.09
P/tB 9.69
EV/EBITDA 57.49
EPS(TTM)0.17
EY0.71%
EPS(NY)0.36
Fwd EY1.48%
FCF(TTM)1.3
FCFY5.42%
OCF(TTM)1.3
OCFY5.42%
SpS16.9
BVpS5.87
TBVpS2.48
PEG (NY)1.29
PEG (5Y)N/A
Graham Number4.73788 (-80.28%)
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 3.11%
ROCE 4.27%
ROIC 2.75%
ROICexc 6.87%
ROICexgc N/A
OM 1.61%
PM (TTM) 1.08%
GM 9.87%
FCFM 7.7%
ROA(3y)1.75%
ROA(5y)-4.65%
ROE(3y)3.16%
ROE(5y)-7.26%
ROIC(3y)2.17%
ROIC(5y)N/A
ROICexc(3y)6.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.37%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-16.37%
OM growth 3YN/A
OM growth 5Y-12.3%
PM growth 3YN/A
PM growth 5Y-22.33%
GM growth 3Y-0.24%
GM growth 5Y-0.49%
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 136.39
Cash Conversion 370.18%
Profit Quality 712.96%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 4.64
F-Score6
WACC8.9%
ROIC/WACC0.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)607.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.55%
EPS 3Y9.35%
EPS 5Y-9.93%
EPS Q2Q%133.33%
EPS Next Y109.45%
EPS Next 2Y64.03%
EPS Next 3Y57.08%
EPS Next 5YN/A
Revenue 1Y (TTM)22.26%
Revenue growth 3Y16.09%
Revenue growth 5Y21.04%
Sales Q2Q%-31.71%
Revenue Next Year17.3%
Revenue Next 2Y13.96%
Revenue Next 3Y11.91%
Revenue Next 5Y10.44%
EBIT growth 1Y101.6%
EBIT growth 3YN/A
EBIT growth 5Y6.15%
EBIT Next Year475.2%
EBIT Next 3Y99.86%
EBIT Next 5Y56.77%
FCF growth 1Y49.53%
FCF growth 3Y51.38%
FCF growth 5Y33.52%
OCF growth 1Y49.53%
OCF growth 3Y51.28%
OCF growth 5Y33.26%

PRIVIA HEALTH GROUP INC / PRVA Fundamental Analysis FAQ

What is the fundamental rating for PRVA stock?

ChartMill assigns a fundamental rating of 5 / 10 to PRVA.


Can you provide the valuation status for PRIVIA HEALTH GROUP INC?

ChartMill assigns a valuation rating of 3 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.


What is the profitability of PRVA stock?

PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 4 / 10.


What is the earnings growth outlook for PRIVIA HEALTH GROUP INC?

The Earnings per Share (EPS) of PRIVIA HEALTH GROUP INC (PRVA) is expected to grow by 109.45% in the next year.